Navigation Links
NJBIZ Honors New Jersey's General Counsels
Date:4/1/2013

WOODCLIFF LAKE, N.J., April 1, 2013 /PRNewswire/ -- Martin L. Wilson, Chief Counsel, Compliance & Litigation, has been named a finalist in the Corporate Compliance Professional category in the 2013 NJBIZ General Counsel of the Year Awards program.  The award program, produced by NJBIZ, New Jersey's premiere business news publication, is sponsored by Nicoll Davis & Spinella LLP, Real Estate Strategies, Update Discovery, Gibbons P.C., Archer & Greiner P.C., K&L Gates, Budd Larner , and Deloitte.  

The General Counsel of the Year Awards program honors New Jersey's standout General Counsels, Chief Legal Officers and corporate compliance professionals for the critical role they play in making their companies successful.  Finalists were selected in six categories: Public Company with revenues up to $1 Billion, Public Company with revenues of more than $1 Billion, Corporate Compliance Professional, Private Company with revenues up to $1 Billion, Private Company with revenues of more than $1 Billion, and Non-profit or Government Organization. 

Finalists and winners were chosen by an independent panel of judges including: Mayor Gerald R. Drasheff , Christine Pellizzari , Christopher Klein , and Anthony Tinari .  Honorees were selected using a scoring system based on: career successes, legal victories and achievements, professional services provided and community service. 

The General Counsel of the Year Awards finalists will be recognized and the winners in each category will be announced during a breakfast awards ceremony on Thursday, June 6, 2013 at the Palace in Somerset Park in Somerset, NJ. 

For more information about the NJBIZ General Counsel of the Year Awards program or to reserve seats to the event, please visit www.njbiz.com/events or contact Melissa Sullenberger at melissas@njbiz.com or (732) 246-5737.  

About Par Pharmaceutical Companies, Inc. 

Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals.  For press release and other company information, visit www.parpharm.com


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
2. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
3. GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
4. Frost & Sullivan Honors Acuo Technologies with 2012 Market Share Leadership Award in Enterprise Imaging Informatics
5. iSALUS Healthcares chairman receives national honors from Samaritans Purse - an international organization providing spiritual and physical aid to victims of war, poverty, natural disaster and disease.
6. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
7. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
8. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
11. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Summary Breast cancer, a malignant neoplasm, is ... cancer in women worldwide, accounting for 16% of all ... of women diagnosed with breast cancer has increased over ... has declined due to earlier diagnosis and better treatment ... the past four decades, especially with increasing usage of ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
Breaking Medicine Technology:
(Date:2/5/2016)... Dallas, Texas (PRWEB) , ... February 05, 2016 , ... ... to allow users to search for and donate to Give To Cure’s campaign ... is an app that lets users make and share payments through a smart device. ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Dr. Justin Scott ... their 2nd Annual No Cost Dental Day to individuals in need. The event is ... of this No Cost Dental Day is to provide dental care to community members ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of ... A hallmark feature of patients with eating disorders is significant self-criticism, and consequently these ... and obsessions are regarded as maladaptive means for coping with this unease, but also ...
(Date:2/5/2016)... ... ... Calls Blacklist has just been updated by mobile app developer Vlad Lee. The ... known bugs within the app. Calls Blacklist allows its users to only have to ... their device’s battery power or memory. It provides a powerful call blocker that is ...
(Date:2/5/2016)... Robles, CA (PRWEB) , ... February 05, 2016 , ... When one is tired of ... be a lifesaver. There are many reasons to rent a storage unit, but before hastily ... service to many; sometimes you simply need more space. But what one is often not ...
Breaking Medicine News(10 mins):